The yield on the benchmark 10-year Treasury note started the week on a tear, jumping to 2.99 percent and toying with the key 3 percent level that could trigger a reaction across global financial markets.
Apple, Alphabet and Samsung’s future forays into medical software could get speedier FDA approval thanks to a new program announced Tuesday.
The FDA is launching a pilot program that will give vetted tech companies pre-approval to work on medical software. The government agency oversees drug and medical device approval, in addition to food and health products. It has already pre-certified....More>>>
Stocks discussed on the in-depth session of Jim Cramer’s Mad Money TV Program, Friday, January 6.
The next week will be about drug and bank stocks. Apart from the earnings, Cramer will be eyeing the JPMorgan Healthcare conference as it is the biggest of its kind and can provide insights into drug stocks. With that, he discussed his game plan for the week.
HDFC Bank (HDFCBK) posted strong and in-line with expectations results for Q4FY2018. The bank reported healthy operational performance, as seen in its net interest income (NII) growing by 18% y-o-y to Rs. 10,657 crore and non-interest incom
Airbus SE Chief Executive Officer Tom Enders sketched out the company’s plans for the next generation of European fighter aircraft and warned that Brexit means the U.K. could miss out on future production.
Airbus’s German operation is working with French warplane specialist
Picking stocks in a bull market is so easy the GEICO caveman could do it. After all, when the broader market indices, like the S&P 500, trade at average price-to-earnings (P/E) and price-to-sales ratios (P/S) of 24.4 and 2.2, respectively, just about every stock in the index is rising.